Feb. 28, 2017
Publisher: Shiseido
R&D/Supply Network
Recognition of effect and efficacy in improving skin wrinkles with retinol acting ingredient acquired for the first time in Japan
“Deep” wrinkles improved in nine weeks
Caution: The contents herein concern approval based on Japan’s Pharmaceutical Affairs Act.
Shiseido Company, Limited (“Shiseido”) has received recognition from the Japanese Ministry of Health, Labour and Welfare for effect and efficacy of a retinol formulation in improving wrinkles. The new product with retinol as the acting ingredient was found to be effective in improving the wrinkle classification grade (see bottom) around level four with use for nine weeks.
Shiseido is the only company in Japan that can manufacture and sell quasi-drug products formulated with retinol as an active ingredient, based on core technology from retinol research spanning nearly 30 years, and will continue research in the anti-aging field for application to skin care products.
Efficacy of retinol in improving wrinkles
A clinical trial was conducted with healthy Japanese women (age 37–54 years, mean age 46 years) who had shallow to deep wrinkles at the corners of the eyes, in accordance with the “Guidelines for Evaluation of Anti-Wrinkle Products” developed by the Japanese Cosmetic Science Society. The women used the new product containing retinol as the active ingredient and a product without retinol for nine weeks. The effect on wrinkles was then judged by dermatologists and analyzed with a measuring instrument.
After nine weeks of use, marked improvement was seen in deep lines from the corners of the eyes and fine wrinkles around the eyes (the so-called “crow’s feet”) (Figure 1). The instrument analysis also showed decreases in wrinkles with the new product compared with the non-retinol product (Figure 2). Marked improvements were also acknowledged from three-dimensional images of wrinkle areas (green) (Figure 3).
The results were also verified through a questionnaire on subjective efficacy, in which the women recognized an improvement in wrinkles with use of the new product.
Figure 1. Representative case of wrinkle improvement with the new product
Download Small Image[60.3KB] Download Large Image[69.6KB]Figure 3. Representative example of wrinkle improvement with 3D image analysis
Download Small Image[58.6KB]Retinol stabilization technology
Retinol has been previously used in quasi-drugs as an active ingredient for rough dry skin, but it is a very unstable component that does not stand up well to heat, sunlight, and oxygen. With the application of formulation technology cultivated through many years of research, Shiseido successfully produced and launched in 1993 a stable formulation in which retinol does not degrade. A unique container for use with retinol formulations has also been developed. Stability is ensured with this formulation technology and container development, making Shiseido the only company in Japan for which retinol as an active ingredient in quasi-drugs has been recognized.
Mechanism of action
Retinol significantly promotes the production of hyaluronic acid in cultured human epidermal keratinocytes (Figure 4). Hyaluronic acid is an important component of skin that contributes to moisture retention and the maintenance of skin elasticity. It is also known to decrease with age. Retinol increases the production of hyaluronic acid and imparts pliability to the skin, reducing wrinkles.
Wrinkle grades (standard): Based on the guidelines developed by the Japanese Cosmetic Science Society
Figure 4. Action of retinol in facilitating the generation of hyaluronic acid
Download Small Image[18.0KB]*The content of the release is correct as of the time of release, but please note that it may in some cases differ from the latest information.
Related News
Oct. 18, 2024
Shiseido Wins Top Award for the 28th time at the 34th IFSCC Congress 2024 Brazil Iguazu Falls
Oct. 8, 2024
Shiseido makes the world's first discovery of the effect of Fermented Camellia Seed Extract to promote the expression of a factor that recruits senescent cell-eliminating immune cells
Oct. 8, 2024
Research as a result of 30 years of collaboration between Shiseido and CBRC reveals a novel mechanism by which skin’s immune cells eliminate senescent cells